Iranian
Biomedical Journal
Volume 30, Issue 1 (1-2026)
IBJ 2026, 30(1): 36-46 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hasanian-Langroudi F, Hedayati M, Esmaeili F, Tohidi M, Siadat S D. Bacteroides thetaiotaomicron and Human Health: A Bibliometric Analysis of Global Research Trends. IBJ 2026; 30 (1) :36-46
URL: http://ibj.pasteur.ac.ir/article-1-5097-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5097-en.html
Farzaneh Hasanian-Langroudi 
, Mehdi Hedayati , Farzad Esmaeili , Maryam Tohidi , Seyed Davar Siadat *
, Mehdi Hedayati , Farzad Esmaeili , Maryam Tohidi , Seyed Davar Siadat *
Abstract:
Bacteroides thetaiotaomicron is a highly abundant Gram-negative anaerobic bacterium that plays a crucial role in maintaining intestinal homeostasis and modulating intestinal diseases. A bibliometric study was conducted to examine global publication trends on B. thetaiotaomicron, using the Scopus database and scientific metrics software over the period 1965-2024. The study investigated variables such as publication year, reference numbers, article type, country, language, and author affiliation. Among the 2,510 articles reviewed on B. thetaiotaomicron, findings indicated that inflammatory bowel disease was the most frequently studied condition. The journal “Anaerobe” published the highest number of articles (n = 68). The United States ranked as the leading country, contributing 969 publications. A total of 14 languages were used in the publications, with 96% written in English. Given the increasing prevalence of digestive diseases and the need for more effective treatments than conventional therapies, B. thetaiotaomicron could be considered a promising therapeutic candidate.
Type of Study: Review Article |
Subject:
Molecular Microbiology
References
1. Levy M, Blacher E, Elinav E. Microbiome, metabolites and host immunity. Curr Opin Microbiol. 2017;35:8-15. [DOI:10.1016/j.mib.2016.10.003]
2. Niccolai E, Martinelli I, Quaranta G, Nannini G, Zucchi E, De Maio F, et al. Fecal microbiota transplantation in amyotrophic lateral sclerosis: Clinical protocol and evaluation of microbiota immunity axis. Methods Mol Biol. 2024;2761:373-96. [DOI:10.1007/978-1-0716-3662-6_27]
3. Donia MS, Fischbach MA. Small molecules from the human microbiota. Science. 2015;349(6246):1254766. [DOI:10.1126/science.1254766]
4. Comstock LE, Coyne MJ. Bacteroides thetaiotaomicron: A dynamic, niche‐adapted human symbiont. Bioessays. 2003;25(10):926-9. [DOI:10.1002/bies.10350]
5. Chang CJ, Lin TL, Tsai YL, Wu TR, Lai WF, Lu CC, et al. Next generation probiotics in disease amelioration. J Food Drug Anal. 2019;27(3):615-22. [DOI:10.1016/j.jfda.2018.12.011]
6. Zocco MA, Ainora ME, Gasbarrini G, Gasbarrini A. Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction. Dig Liver Dis. 2007;39(8):707-12. [DOI:10.1016/j.dld.2007.04.003]
7. Kitamura M, Okuyama M, Tanzawa F, Mori H, Kitago Y, Watanabe N, et al. Structural and functional analysis of a glycoside hydrolase family 97 enzyme from bacteroides thetaiotaomicron. J Biol Chem. 2008;283(52):36328-37. [DOI:10.1074/jbc.M806115200]
8. Kau AL, Ahern PP, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature. 2011;474(7351):327-36. [DOI:10.1038/nature10213]
9. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904. [DOI:10.1152/physrev.00045.2009]
10. Li K, Hao Z, Du J, Gao Y, Yang S, Zhou Y. Bacteroides thetaiotaomicron relieves colon inflammation by activating aryl hydrocarbon receptor and modulating CD4+ T cell homeostasis. Int Immunopharmacol. 2021;90:107183. [DOI:10.1016/j.intimp.2020.107183]
11. Lee JH, Kwon SJ, Han JY, Cho SH, Cho YJ, Park JH. A mucin-responsive hybrid two-component system controls bacteroides thetaiotaomicron colonization and gut homeostasis. J Microbiol. 2022;60(2):215-23. [DOI:10.1007/s12275-022-1649-3]
12. Bar-Ilan J. Citations to the "Introduction to informetrics" indexed by WOS, Scopus and Google Scholar. Scientometrics. 2010;82(3):495-506. [DOI:10.1007/s11192-010-0185-9]
13. Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. scientometrics. 2010;84(2):523-38. [DOI:10.1007/s11192-009-0146-3]
14. Watson AR, Füssel J, Veseli I, DeLongchamp JZ, Silva M, Trigodet F, et al. Metabolic independence drives gut microbial colonization and resilience in health and disease. Genome Biol. 2023;24(1):78. [DOI:10.1186/s13059-023-02924-x]
15. Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362(6416):776-80. [DOI:10.1126/science.aau5812]
16. Durack J, Lynch SV. The gut microbiome: Relationships with disease and opportunities for therapy. J Exp Med. 2019;216(1):20-40. [DOI:10.1084/jem.20180448]
17. Qv L, Mao S, Li Y, Zhang J, Li L. Roles of gut bacteriophages in the pathogenesis and treatment of inflammatory bowel disease. Front Cell Infect Microbiol. 2021;11:755650. [DOI:10.3389/fcimb.2021.755650]
18. Cho S-H, Cho YJ, Park JH. The human symbiont bacteroides thetaiotaomicron promotes diet-induced obesity by regulating host lipid metabolism. J Microbiol. 2022;60(1):118-27. [DOI:10.1007/s12275-022-1614-1]
19. Wrzosek L, Miquel S, Noordine ML, Bouet S, Chevalier-Curt MJ, Robert V, et al. Bacteroides thetaiotaomicron and faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013;11:61. [DOI:10.1186/1741-7007-11-61]
20. Tsai HH, Hart CA, Rhodes JM. Production of mucin degrading sulphatase and glycosidases by bacteroides thetaiotaomicron. Lett Appl Microbiol. 1991;13:97-101. [DOI:10.1111/j.1472-765X.1991.tb00580.x]
21. Bhattarai Y, Jie S, Linden DR, Ghatak S, Mars RA, Williams BB, et al. Bacterially derived tryptamine increases mucus release by activating a host receptor in a mouse model of inflammatory bowel disease. iScience. 2020;23(12):101798. [DOI:10.1016/j.isci.2020.101798]
22. Gal-Mandelbaum N, Carasso S, Kedem A, Ziv T, Keshet-David R, Abboud R, et al. Dietary carbohydrates alter immune-modulatory functionalities and DNA inversions in bacteroides thetaiotaomicron. Nat Commun. 2025;16(1):4938. [DOI:10.1038/s41467-025-60202-9]
23. Ndeh DA, Nakjang S, Kwiatkowski KJ, Sawyers C, Koropatkin NM, Hirt RP, et al. A Bacteroides thetaiotaomicron genetic locus encodes activities consistent with mucin O-glycoprotein processing and N-acetylgalactosamine metabolism. Nat Commun. 2025;16(1):3485. [DOI:10.1038/s41467-025-58660-2]
24. Zafar H, Saier Jr MH. Gut bacteroides species in health and disease. Gut Microbes. 2021;13(1):1-20. [DOI:10.1080/19490976.2020.1848158]
25. Wrigley J, Carden V, von Isenburg M. Bibliometric mapping for current and potential collaboration detection. J Med Libr Assoc. 2019;107(4):597-600. [DOI:10.5195/jmla.2019.764]
26. Llewellyn N, Carter DR, DiazGranados D, Pelfrey C, Rollins L, Nehl EJ. Scope, influence, and interdisciplinary collaboration: The publication portfolio of the NIH Clinical and Translational Science Awards (CTSA) program from 2006 through 2017. Eval Health Prof. 2020;43(3):169-79. [DOI:10.1177/0163278719839435]
27. Porter NT, Canales P, Peterson DA, Martens EC. A subset of polysaccharide capsules in the human symbiont bacteroides thetaiotaomicron promotes increased competitive fitness in the mouse gut. Cell Host Microbe. 2017;22(4):494-506. [DOI:10.1016/j.chom.2017.08.020]
28. Luo ZQ, Huang YJ, Chen ZH, Lu CY, Zhou B, Gong XH, et al. A decade of insight: Bibliometric analysis of gut microbiota's role in osteoporosis. Front Med. 2024;11:1409534. [DOI:10.3389/fmed.2024.1409534]
29. Wang Y, Li D, Jia Z, Hui J, Xin Q, Zhou Q, et al. A bibliometric analysis of research on the links between gut microbiota and atherosclerosis. Front Cardiovasc Med. 2022;9:941607. [DOI:10.3389/fcvm.2022.941607]
30. Zyoud SH, Alalalmeh SO, Hegazi OE, Shakhshir M, Abushamma F, Al-Jabi SW. An examination of global research trends for exploring the associations between the gut microbiota and nonalcoholic fatty liver disease through bibliometric and visualization analysis. Gut Pathog. 2024;16(1):31 [DOI:10.1186/s13099-024-00624-w]
31. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. Lancet. 2017;390(10114):2769-78. [DOI:10.1016/S0140-6736(17)32448-0]
32. Ananthakrishnan AN, Kaplan GG, Ng SC. Changing global epidemiology of inflammatory bowel diseases: Sustaining health care delivery into the 21st century. Clin Gastroenterol Hepatol. 2020;18(6):1252-60. [DOI:10.1016/j.cgh.2020.01.028]
33. Delday M, Mulder I, Logan ET, Grant G. Bacteroides thetaiotaomicron ameliorates colon inflammation in preclinical models of Crohn's disease. Inflamm Bowel Dis. 2019;25(1):85-96. [DOI:10.1093/ibd/izy281]
34. Durant L, Stentz R, Noble A, Brooks J, Gicheva N, Reddi D, et al. Bacteroides thetaiotaomicron-derived outer membrane vesicles promote regulatory dendritic cell responses in health but not in inflammatory bowel disease. Microbiome. 2020;8(1):88. [DOI:10.1186/s40168-020-00868-z]
35. Xu B, Fu Y, Yin N, Qin W, Huang Z, Xiao W, et al. Bacteroides thetaiotaomicron and faecalibacterium prausnitzii served as key components of fecal microbiota transplantation to alleviate colitis. Am J Physiol Gastrointest Liver Physiol. 2024;326(5):607-21. [DOI:10.1152/ajpgi.00303.2023]
36. Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe. 2008;4(5):447-57. [DOI:10.1016/j.chom.2008.09.007]
37. Feng J, Qian Y, Zhou Z, Ertmer S, Vivas EI, Lan F, et al. Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions. Cell Host Microbe. 2022;30(2):200-15. [DOI:10.1016/j.chom.2021.12.006]
38. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446-50. [DOI:10.1038/nature12721]
39. Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015;350(6264):1079-84. [DOI:10.1126/science.aad1329]
40. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881-4. [DOI:10.1126/science.291.5505.881]
41. Kamada N, Seo S-U, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nature Reviews Immunology. 2013;13(5):321-35. [DOI:10.1038/nri3430]
42. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology. 2016;14(1):20-32. [DOI:10.1038/nrmicro3552]
43. Wexler HM. Bacteroides: The good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593-621. [DOI:10.1128/CMR.00008-07]
44. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De Los Reyes-gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185. [DOI:10.3389/fmicb.2016.00185]
45. Faith JJ, Guruge JL, Charbonneau M, Subramanian S, Seedorf H, Goodman AL, et al. The long-term stability of the human gut microbiota. Science. 2013;341(6141):1237439. [DOI:10.1126/science.1237439]
46. Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes. 2012;3(4):289-306. [DOI:10.4161/gmic.19897]
47. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. Polysaccharide utilization by gut bacteria: Potential for new insights from genomic analysis. Nat Rev Microbiol. 2008;6(2):121-31. [DOI:10.1038/nrmicro1817]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |